BioRestorative Therapies (BRTX) reports director Esha Randhawa’s insider status
Rhea-AI Filing Summary
BioRestorative Therapies, Inc. has reported an initial statement of beneficial ownership for Esha Randhawa, who is identified as a director of the company. The report shows no reported transactions, no share purchases or sales, and no listed derivative positions for Randhawa.
Positive
- None.
Negative
- None.
Key Figures
Reported buy transactions: 0
Reported sell transactions: 0
Reported holding entries: 0
3 metrics
Reported buy transactions
0
Buy transactions count in the Form 3 transaction summary
Reported sell transactions
0
Sell transactions count in the Form 3 transaction summary
Reported holding entries
0
Holding entries in the Form 3 summary of positions
Key Terms
beneficial ownership, ten percent owner, Rule 10b5-1
3 terms
beneficial ownership regulatory
"Initial statement of beneficial ownership for Esha Randhawa as a director"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
ten percent owner regulatory
"The ten percent owner status is indicated as not applicable for Randhawa"
Rule 10b5-1 regulatory
"Rule 10b5-1 trading plan status is referenced but not marked active"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does the BioRestorative Therapies (BRTX) Form 3 for Esha Randhawa show?
The Form 3 identifies Esha Randhawa as a director of BioRestorative Therapies, Inc.. It reports no stock purchases, sales, or derivative positions for Randhawa, and no other transactions are listed in this initial ownership statement.
Are there any buy or sell transactions reported for BRTX director Esha Randhawa?
No. The Form 3 for BRTX shows 0 reported buy transactions and 0 reported sell transactions for director Esha Randhawa. The transaction summary indicates no equity trades or derivative exercises associated with this reporting person.
Does the BioRestorative Therapies (BRTX) Form 3 list any derivative securities for Esha Randhawa?
No derivative securities are listed. The derivative summary for BRTX shows no reported option, warrant, or other derivative positions for director Esha Randhawa in this initial beneficial ownership report.
Is Esha Randhawa a ten percent owner of BioRestorative Therapies (BRTX)?
The Form 3 marks the ten percent owner status as not applicable for Esha Randhawa. She is reported as a director of BioRestorative Therapies, Inc., without being identified as a ten percent beneficial owner.
Does the BRTX Form 3 indicate use of a Rule 10b5-1 trading plan for Esha Randhawa?
No. The Rule 10b5-1 trading plan indicator is not marked as active for this Form 3 relating to BRTX director Esha Randhawa, and there are no reported trades that would be associated with such a plan.